- Zosia Kmietowicz
- 1London
Campaigners have called on the government to take action to end the “ongoing secrecy” that surrounds the reporting of clinical trials.
In a letter to the Times they write that despite drug companies being required by law to report negative as well as positive results from clinical trials, the reality is somewhat different.1
“We wish that drug companies truly were compelled to be transparent. In reality, vitally important information about drug trials continues to be …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking